Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Non-Current Deffered Revenue (2016 - 2025)

Healthstream (HSTM) has disclosed Non-Current Deffered Revenue for 12 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 18.79% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 18.79% decrease, with the full-year FY2025 number at $1.3 million, down 18.79% from a year prior.
  • Non-Current Deffered Revenue was $1.3 million for Q4 2025 at Healthstream, up from $1.3 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $2.9 million in Q4 2022 to a low of $990000.0 in Q1 2022.
  • A 5-year average of $1.8 million and a median of $1.6 million in 2021 define the central range for Non-Current Deffered Revenue.
  • Peak YoY movement for Non-Current Deffered Revenue: surged 158.79% in 2023, then plummeted 39.01% in 2024.
  • Healthstream's Non-Current Deffered Revenue stood at $1.6 million in 2021, then skyrocketed by 85.53% to $2.9 million in 2022, then fell by 26.15% to $2.2 million in 2023, then dropped by 23.7% to $1.7 million in 2024, then dropped by 18.79% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Non-Current Deffered Revenue are $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.2 million (Q2 2025).